ArticleFrontiers in oncology2024

Major response of a peritoneal mesothelioma to nivolumab and ipilimumab: a case report, molecular analysis and review of literature.

Marie-Florence Reveneau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.